AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of October 3, 2022Management Agreement • November 8th, 2022 • Royalty Pharma PLC • Pharmaceutical preparations • New York
This AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 3rd day of October, 2022, among ROYALTY PHARMA PLC, a public limited company established under the laws of England and Wales (the “Company”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
SECOND AMENDED AND RESTATED MANAGEMENT AGREEMENT Dated as of October 3, 2022Management Agreement • November 8th, 2022 • Royalty Pharma PLC • Pharmaceutical preparations • New York
This SECOND AMENDED AND RESTATED MANAGEMENT AND SERVICES AGREEMENT (this “Agreement”) is effective as of the 3rd day of October, 2022, among ROYALTY PHARMA INVESTMENTS 2019 ICAV having its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (hereinafter called the “ICAV”), and RP MANAGEMENT, LLC, a Delaware limited liability company (the “Manager”). Capitalized terms used in the preamble and recitals of this Agreement and not otherwise defined therein are defined in Section 1 (Definitions).
